• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Letrozole Farmoz
    / BioAvenir


    Active Ingredient
    Letrozole 2.5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    30 X 2.5 mg

    partial basket chart 29534 12477

    Related information


    Dosage

    One tablet daily.
    See prescribing information for full details.


    Indications

    First-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer.Treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.


    Contra-Indications

    Hypersensitivity. Pregnancy and lactation. Premenopausal status. Severe liver disease.


    Special Precautions

    See prescribing information for full details.


    Side Effects

    Very common: Hot flushes, pain in bones and joints.
    Common: Headache, rash, dizziness, general unwell feeling, GI disorders such as nausea, vomiting, indigestion, constipation, diarrhea; increase or loss of appetite, muscle pain, osteoporosis, depression, weight gain, hair loss, fatigue, increased sweating, high cholesterol level.
    See prescribing information for full details.


    Manufacturer
    Farmoz S.A.
    Licence holder
    CLOSE